Evidence map›Paper›PMID 40614800›Full record

ArticleMicrovascular research2025

Kinetics of thromboxane A2 receptor-driven vascular tone in the cerebral cortex ex vivo.

Simone Woodruff, Benjamin Zimmerman, Kevin J Elk, Jennifer E Jenks, Danica Bojovic, Anusha Mishra

Abstract read
In one paragraph

Article in Microvascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simone WoodruffJungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States. Electronic address: woodrufs@ohsu.edu.
Benjamin ZimmermanJungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States; Helfgott Research Institute, National University of Natural Medicine, 49 S Porter St, Portland, OR 97201, United States. Electronic address: zimmermb@ohsu.edu.
Kevin J ElkJungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States. Electronic address: elk@ohsu.edu.
Jennifer E JenksJungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States. Electronic address: jenksj@ohsu.edu.
Danica BojovicJungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States; Vollum Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States. Electronic address: bojovic@ohsu.edu.
Anusha MishraJungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States. Electronic address: mishraa@ohsu.edu.

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Zachary Beattie · 2020 to 2026
$28.6M
Building Research across Interdisciplinary Gaps (BRIDG) R90 Training Program - Administrative SupplementR90AT008924 · NCCIH · NATIONAL UNIVERSITY OF NATURAL MEDICINE · PI BRADLEY, RYAN D, ZWICKEY, HEATHER LEA · 2015 to 2025
$5.2M
Medical Scientist Training Program of Oregon Health & Science UniversityT32GM141938 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI CHEN, YABING · 2021 to 2025
$4.6M
Neuroscience of Aging, Neurodegeneration and Alzheimer’s DiseaseT32AG055378 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOB RABER, HENRYK F URBANSKI · 2018 to 2026
$4.3M
Pericyte control of capillary perfusion in the Alzheimer's disease brainR01AG081840 · NIA · SEATTLE CHILDREN'S HOSPITAL · PI Andy Y Shih · 2023 to 2026
$3.4M
Astrocyte regulation of cerebral blood flow at the intersection of ischemia and Alzheimer's diseaseR01NS134592 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Anusha Mishra · 2023 to 2026
$2.7M
Glial regulation of neurovascular coupling in CNS disordersR01NS110690 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MISHRA, ANUSHA · 2019 to 2023
$1.7M
Contribution of endothelin 1 mediated ischemic vascular dysfunction to Alzheimer's diseaseF30AG089943 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Simone Woodruff · 2024 to 2026
$164k
NCCIH NIH HHS R90 AT008924NIA NIH HHS F30 AG089943NIA NIH HHS P30 AG066518NIA NIH HHS R01 AG081840NIA NIH HHS T32 AG055378NIGMS NIH HHS T32 GM141938NINDS NIH HHS R01 NS110690NINDS NIH HHS R01 NS134592
6 · The paper itself

Abstract

Ex vivo imaging in acute cortical brain slices is a valuable tool to assess neurovascular coupling and is particularly useful for studying active, local changes in microvascular compartments in isolation from upstream or downstream changes in flow. However, the lack of vascular perfusion pressure ex vivo results in loss of vascular tone, which must be restored prior to experiments to unmask dilatory signals. The thromboxane A2 receptor agonist U46619 is a widely used preconstrictor, yet its dose-response properties and kinetics of action on different vascular segments are not fully known. Here, we characterize the effects of U46619 on cortical arterioles and capillaries in ex vivo slices from rats and mice. Dose response curves tested in acute rat brain slices using 0 to 1000 nM U46619 showed that maximal constriction is reached at ∼300 nM in both arterioles and capillaries. Extended application of 200 nM U46619 (∼66 % maximal dose) over 2 h revealed that, on average, capillaries constrict faster than arterioles in rat brain slices. Cross-species examination in mouse tissue showed that vessels in mouse brain slices respond faster and constrict stronger on average than in rat brain slices, and that mouse capillaries also constrict faster than mouse arterioles. Our observations suggest that near-maximal preconstriction can be achieved in ex vivo experiments using 200-300 nM U46619, with a minimum incubation time of 20 min for studies involving capillaries and at least 30 min for studies involving arterioles.

Indexed as

CapillariesCerebral CortexCerebrovascular CirculationReceptors, Thromboxane A2, Prostaglandin H2VasoconstrictionVasodilation15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidAnimalsArteriolesDose-Response Relationship, DrugKineticsMaleMiceMice, Inbred C57BLRatsRats, Sprague-Dawley15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidReceptors, Thromboxane A2, Prostaglandin H2Vasoconstrictor AgentsArterioleCapillaryMicrovascularThromboxane A2 receptorU46619Vascular tone

Identifiers

PMID40614800
PMCPMC12306426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.